Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Percutaneous adhering preparation containing hydrochloride lignocaine and peppermintcamphor

A lidocaine hydrochloride and transdermal patch technology is applied in the directions of anti-inflammatory agents, sheet delivery, drug devices, etc., and can solve the problems of restricting the area of ​​transdermal preparations, and the transdermal speed cannot meet the treatment requirements.

Inactive Publication Date: 2007-07-25
陶燃
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The dosage of the transdermal drug delivery system is determined by the effective drug release area and the transdermal rate of the drug. Due to their physical and chemical properties, the transdermal rate of most drugs cannot meet the treatment requirements, and the practical application restricts the transdermal preparation. the area of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment 1, preparation contains the transdermal patch of lidocaine hydrochloride and menthol. The method comprises the steps of dissolving the medicine in water, adding it to a dressing, stirring to form a gel, and packaging to make a gel-like transdermal patch.

Embodiment 2

[0012] Embodiment 2. Using gel transdermal patch during treatment with ultrasonic conductivity meter.

[0013] Put the patch prepared in Example 1 into the corresponding placement position of the treatment head, and press it firmly. Remove the anti-adhesive paper on the concave surface of the patch, stick the patch together with the treatment head to the skin of the treatment area, and remove it after the treatment is over.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A transdermal paster for treating acute or chronic local pain is prepared from lidocain hydrochloride and methol. It can be used for the ultrasonic-type, ion leading-in type, electric perforating type, or high-pressure gas type medicine supplying system.

Description

technical field [0001] The invention relates to an analgesic composed of two kinds of substances combined application-a transdermal patch preparation combined application of lidocaine hydrochloride and menthol. Further, the patent of the present invention relates to the use of low-frequency ultrasonic drug delivery system to treat various acute and chronic local pains. Background technique [0002] Various acute and chronic local pains are a social problem, and the World Health Organization now lists pain as a disease. There are millions of patients suffering from various pains every day in our country. At present, various acute and chronic pains are mainly treated with oral drugs for symptomatic treatment. Oral drugs can severely stimulate the gastrointestinal tract, and the curative effect is short and the effect is not obvious. Especially for some local pains, oral drugs are difficult to reach, which makes the effect worse. . Therefore, there is a need to provide a dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/167A61K9/70A61M37/00A61P29/00A61K31/045
Inventor 陶燃
Owner 陶燃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products